Literature DB >> 3882317

Influence of body composition on insulin clearance.

H Yki-Järvinen, V A Koivisto, S L Karonen.   

Abstract

The effect of body composition on clearance of infused insulin was studied in 21 young normal weight (relative body weight 107 +/- 2%, of ideal mean +/- SEM) healthy subjects. In each subject, the per cent of body weight made up of muscle and fat tissue (% muscle and % fat) were determined. Clearance of insulin was estimated during infusion of insulin at the rate of 40 mU/m2/min under maintenance of normoglycaemia using the euglycaemic clamp technique. Steady-state plasma insulin levels (92.6 +/- 3.2 mU/litre) correlated negatively with % muscle (r = -0.60, P less than 0.01), and positively with % fat (r = 0.55, P less than 0.01). Clearance of insulin was directly related to % muscle (r = 0.60, P less than 0.01), and inversely related to % fat (r = -0.48, P less than 0.01). Steady-state plasma insulin levels or insulin clearance did not correlate with relative body weight. Multiple linear regression analysis revealed a significant multivariate correlation between the rate of insulin clearance versus % muscle and % fat (r = 0.62, P less than 0.02). The changes in % muscle and % fat could predict 37% of the observed interindividual variance of insulin clearance. These results indicate that insulin clearance depends on body composition and is higher in muscular than in adipose subjects. This difference may reflect either a greater distribution space of insulin in muscular as compared to adipose subjects or an influence of body composition on insulin catabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882317     DOI: 10.1111/j.1475-097x.1985.tb00745.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  8 in total

1.  Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.

Authors:  H Laine; H Yki-Jarvinen; O Kirvela; T Tolvanen; M Raitakari; O Solin; M Haaparanta; J Knuuti; P Nuutila
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

2.  Association of hip circumference with incident diabetes and coronary heart disease: the Atherosclerosis Risk in Communities study.

Authors:  Emily D Parker; Mark A Pereira; June Stevens; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2009-02-18       Impact factor: 4.897

Review 3.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

4.  Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.

Authors:  Maude Gagnon-Auger; Patrick du Souich; Jean-Patrice Baillargeon; Elisabeth Martin; Pascal Brassard; Julie Ménard; Jean-Luc Ardilouze
Journal:  Diabetes Care       Date:  2010-09-14       Impact factor: 19.112

5.  Relationships of Insulin Action to Age, Gender, Body Mass Index, and Waist Circumference Present Diversely in Different Glycemic Statuses among Chinese Population.

Authors:  Shao-Jie Pang; Qing-Qing Man; Shuang Song; Peng-Kun Song; Zhen Liu; Yu-Qian Li; Shan-Shan Jia; Jing-Zhong Wang; Wen-Hua Zhao; Jian Zhang
Journal:  J Diabetes Res       Date:  2018-08-23       Impact factor: 4.011

6.  Differences in Body Fat Distribution Play a Role in the Lower Levels of Elevated Fasting Glucose amongst Ghanaian Migrant Women Compared to Men.

Authors:  Mary Nicolaou; Anton E Kunst; Wim B Busschers; Irene G van Valkengoed; Henriette Dijkshoorn; Linda Boateng; Lizzy M Brewster; Marieke B Snijder; Karien Stronks; Charles Agyemang
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

7.  Hyperinsulinemia in individuals with obesity: Role of insulin clearance.

Authors:  Mee Kyoung Kim; Gerald M Reaven; Yii-Der Ida Chen; Eric Kim; Sun H Kim
Journal:  Obesity (Silver Spring)       Date:  2015-11-02       Impact factor: 5.002

8.  Dipeptidyl peptidase-4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes.

Authors:  Takahiro Abe; Yasuhiro Matsubayashi; Sayaka Muragishi; Akihiro Yoshida; Hideki Suganami; Kenichi Furusawa; Kazuya Fujihara; Shiro Tanaka; Kohei Kaku; Hirohito Sone
Journal:  J Diabetes Investig       Date:  2021-05-26       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.